ALT
Altimmune·NASDAQ
--
--(--)
--
--(--)
6.20 / 10
Outperform
Analyst consensus is bullish with 50% Strong Buy and 50% Buy ratings from two institutions, yet the price has fallen -13.96% recently, indicating a mismatch. Fund flow is positive (score 7.67/10), showing money inflow across most categories, but the overall trend is negative. This divergence between positive sentiment/fund flow and negative price trend underscores uncertainty.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-07
InstitutionCitizens
Times predicted4
Historical Win Rate50.0%
Is money flowing into or out of ALT?
- ALT holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.20/10 (Outperform).
